期刊文献+

乙肝治疗性多肽免疫刺激复合物的制备及鉴定 被引量:4

Preparation and identification of immunostimulating complexes from a hepatitis B therapeutic peptide
暂未订购
导出
摘要 目的 为有效提高小分子多肽在体诱导CTL应答的能力 ,制备了乙肝治疗性多肽免疫刺激复合物 (ISCOMs) ,并对其形成进行了鉴定。方法 乙肝治疗性多肽ISCOMs采用透析法制备获得 ,并经小分子多肽的SDS PAGE电泳法确定了复合物中小分子多肽的存在 ,采用Bradfords法测定了复合物中多肽的结合量。结果 在电镜下呈典型的蜂巢状亚微型颗粒结构 ,所制备的ISCOMs中多肽的结合量约为 0 .30mg/ml。结论 ISCOMs的成功制备 。 Objective To prepare and characterize immunostimulatory complexes(ISCOMs) from a hepatitis B therapeutic peptide in order to improve the cytotoxic T lymphocyte(CTL) responses induced by short peptide antigen in vivo . Methods The ISCOMs were prepared by dialysis approach, and the formation was observed with electron microscopy. The short polypeptide in the ISCOMs was analyzed with SDS PAGE method and the content of peptide incorporated into the ISCOMs was determined by Bradford's method. Results Typical honeycomb like structure of ISCOMs was observed with electron microscope, and hepatitis B peptide content incorporated into the ISCOMs was approximately 0.30 mg/ml. Conclusion The ISCOMs were successfully prepared from the short polypeptide which founded a basis for the further study on immune features of the complexes.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2000年第10期927-930,共4页 Journal of Third Military Medical University
基金 国家自然科学基金资助项目 !(397890 1 0 )
关键词 免疫刺激复合物 制备 鉴定 乙型肝炎 immunostimulating compexes preparation characterization
  • 相关文献

参考文献7

  • 1[1]Morein B,Sundquist B,Hoglund S,et al.Iscom,a novel structure for antigenic presentation of membrane proteins from enveloped viruses[J].Nature,1984,308(5 958):457-460.
  • 2[2]Takahashi H,Takeshita T,Morein B,et al.Induction of CD8+ cytotoxic T cells by immunization with purified HIV-1 envelope protein in ISCOMs[J].Nature,1990,344(6 269):873-875.
  • 3Samlaska CP,张国毅.浅层血栓性静脉炎Ⅰ.原发性高凝状态[J].国外医学(皮肤性病学分册),1991,17(3):163-166. 被引量:1
  • 4[4]Heeg K,Kuon W,Wagner H.Vaccination of class Ⅰ major histocompatibility complex (MHC)-restricted murine CD8+cytotoxic T lymphocytes towards soluble antigens:immunostimulating-ovalbumin complexes enter the class Ⅰ MHC-restricted antigen pathway and allow sensitization against the immunodominant peptide[J].Eur J Immunol,1991,21(6):1 523-1 527.
  • 5[5]Sjolander A,CoxJ C,Barr I G.ISCOMs:an adjuvant with multiple functions[J].J Leukoc Biol,1998,64(6):713-723.
  • 6[6]Barr I G,Mitchell G F.ISCOMs (immunostimulating complexes):the first decade[J].Immunol Cell Biol,1996,74(1):8-25.
  • 7[7]Morein B.The ISCOM antigen-presenting system[J].Nature,1988,332(6 161):287-288.

同被引文献39

  • 1赫兢,辛绍杰,毛远丽,貌盼勇,沈宏辉,杨健洋,徐军,孔维.前S2抗原基因对乙型肝炎DNA疫苗免疫应答的影响[J].世界华人消化杂志,2004,12(9):2196-2198. 被引量:2
  • 2孙建和,陈怀青,陆承平.嗜水气单胞菌疫苗的研制[J].畜牧与兽医,1995,27(5):202-205. 被引量:29
  • 3陈月英,钱冬,沈智华,沈锦玉,曹铮,尹文林,张念慈.养殖鱼类细菌性败血症的菌苗制备技术[J].水产学报,1996,20(2):125-131. 被引量:33
  • 4孙建和,严亚贤,陈怀青,陆承平.嗜水气单胞菌亚单位疫苗的研制[J].中国兽医学报,1996,16(1):11-15. 被引量:30
  • 5Belyakov IM, Ahlers JD, Nabel GJ, et al. Generation of functionally active HIV- 1 specific CD8^+ CTL in intestinal mucosa following mucosal, systemic or mixed primeboost immunization [ J ]. Virology, 2008,381(1 ) : 106 - 115.
  • 6Hutchings CL, Birkett AJ, Moore AC, et al. Combination of protein and viral vaccines induces potent cellular and humoral immune responses and enhanced protection from murine malaria ehallenge[J]. Infect Immun, 2007, 75 (12) : 5819 - 5826.
  • 7Beveridge NE, Price DA, Casazza JP, et al. Immunization with BCG and recombinant MVA85A induces long - lasting, polyfunctional Mycobacterium tuberculosis- specific CD4^+ memory T lymphocyte populations[J]. Eur J Immunol, 2007,37(11) :3089- 100.
  • 8Burgers WA, Chege GK, Muller TL, et al. Broad, high - magnitude and multifunctional CD4^+ and CD8^+ T - cell responses elicited by a DNA and modified vaceinia Ankara vaccine containing human immunod-eficiency virus type 1 subtype C genes in baboons[J]. J Gen Virol, 2009,90(Pt 2) :468 - 480.
  • 9Arian PM, Gulley JL, Madan RA, et al. Preclinical and clinical studies of recombinant poxvirus vaccines for carcinoma therapy[J]. Crit Rev Immunol, 2007,27(5) :451 - 462.
  • 10Marshall DJ, Rudnick KA, McCarthy SG, et al. Interleukin- 18 enhances Th1 immunity and tumor protection of a DNA vaccine[J ]. Vaccine, 2006,24 (3) : 244 - 253.

引证文献4

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部